comparemela.com

Page 3 - ஸ்காட் ஹால்பெரின் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Halifax trial of Canadian-made COVID-19 vaccine having trouble finding participants

Halifax trial of Canadian-made COVID-19 vaccine having trouble finding participants | iNFOnews

Keith Doucette Dr. John Lewis, CEO of Edmonton-based Entos Pharmaceuticals Inc., is shown in a handout photo. Clinical trials for a Canadian-made COVID-19 vaccine have hit a roadblock with the success of increasing vaccination rates in Nova Scotia.THE CANADIAN PRESS/HO May 27, 2021 - 1:00 AM HALIFAX - A Canadian-made COVID-19 vaccine undergoing clinical trials in Halifax is having trouble recruiting enough participants as vaccination rates increase in Nova Scotia. The Canadian Centre for Vaccinology at Dalhousie University is trying to complete the second stage of the Phase 1 trial for a vaccine developed by Edmonton-based Entos Pharmaceuticals but says it s hard to find volunteers as more people get shots.

Manque de participants pour les essais cliniques d un vaccin canadien à Halifax

Manque de participants pour les essais cliniques d un vaccin canadien à Halifax
lactualite.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lactualite.com Daily Mail and Mail on Sunday newspapers.

UBC begins mix-and-match study of Covid-19 vaccines in Canada

UBC begins mix-and-match study of Covid-19 vaccines in Canada 21 May 2021 (Last Updated May 21st, 2021 17:27) The University of British Columbia is set to study the effects of mixing different Covid-19 vaccines. Share Article The trial will enrol a total of 1,300 participants. Credit: The University of British Columbia. The University of British Columbia (UBC) has started a clinical study to assess the effects of mixing different brands of approved Covid-19 vaccines in Canada. Named MOSAIC, the study will examine the safety and effectiveness of two separate vaccines for the first and second doses. It is also intended to evaluate increased intervals between two doses.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.